4.3 Article

Patients with McCune-Albright syndrome have a broad spectrum of abnormalities in the gastrointestinal tract and pancreas

Journal

VIRCHOWS ARCHIV
Volume 470, Issue 4, Pages 391-400

Publisher

SPRINGER
DOI: 10.1007/s00428-017-2086-2

Keywords

McCune-Albright syndrome; GNAS; Intraductal papillary mucinous neoplasm; Gastric heterotopia

Categories

Funding

  1. Intramural Research Program of the National Institute of Dental and Craniofacial Research
  2. NIH/NCI [P50 CA62924]
  3. NIH/NIDDK [K08 DK107781]
  4. Sol Goldman Pancreatic Cancer Research Center
  5. Buffone Family Gastrointestinal Cancer Research Fund
  6. Kaya Tuncer Career Development Award in Gastrointestinal Cancer Prevention
  7. AGA-Bernard Lee Schwartz Foundation Research Scholar Award in Pancreatic Cancer
  8. Sidney Kimmel Foundation for Cancer Research Kimmel Scholar Award
  9. AACR-Incyte Corporation Career Development Award for Pancreatic Cancer Research
  10. Rolfe Pancreatic Cancer Foundation
  11. Joseph C Monastra Foundation for Pancreatic Cancer Research
  12. Gerald O Mann Charitable Foundation
  13. Sigma Beta Sorority
  14. Tampa Bay Fisheries Inc.
  15. Dutch Digestive Foundation [MLDS CDG 14-02]

Ask authors/readers for more resources

McCune-Albright Syndrome (MAS) is a rare sporadic syndrome caused by post-zygotic mutations in the GNAS oncogene, leading to constitutional mosaicism for these alterations. Somatic activating GNAS mutations also commonly occur in several gastrointestinal and pancreatic neoplasms, but the spectrum of abnormalities in these organs in patients with MAS has yet to be systematically described. We report comprehensive characterization of the upper gastrointestinal tract in seven patients with MAS and identify several different types of polyps, including gastric heterotopia/metaplasia (7/7), gastric hyperplastic polyps (5/7), fundic gland polyps (2/7), and a hamartomatous polyp (1/7). In addition, one patient had an unusual adenomatous lesion at the gastroesophageal junction with high-grade dysplasia. In the pancreas, all patients had endoscopic ultrasound findings suggestive of intraductal papillary mucinous neoplasm (IPMN), but only two patients met the criteria for surgical intervention. Both of these patients had IPMNs at resection, one with low-grade dysplasia and one with high-grade dysplasia. GNAS mutations were identified in the majority of lesions analyzed, including both IPMNs and the adenomatous lesion from the gastroesophageal junction. These studies suggest that there is a broad spectrum of abnormalities in the gastrointestinal tract and pancreas in patients with MAS and that patients with MAS should be evaluated for gastrointestinal pathology, some of which may warrant clinical intervention due to advanced dysplasia.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available